|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 14-09-16 | CHUGAI PHARMACEUTICAL : Roche's $8 billion InterMune buy not a signal for more big deals | RE |
| 14-09-04 | Roche : rules out mega deals, open to smaller ones - paper | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Chief Tech/Sci/R&D Officer | 71 | 2002-03-31 | |
Carla Fiankan
LAW | General Counsel | - | 2011-07-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.71% | -6.35% | -4.87% | +9.03% | 46.05B | ||
| +0.21% | -2.98% | +340.68% | +519.93% | 43.59B | ||
| +1.74% | -2.24% | +37.28% | +21.57% | 42.35B | ||
| +1.38% | -3.28% | +3.23% | +65.60% | 38.86B | ||
| -1.44% | -5.26% | +8.78% | +36.85% | 32.24B | ||
| +0.87% | -2.60% | - | - | 17.16B | ||
| +0.75% | -0.64% | +18.07% | +110.32% | 16.28B | ||
| -0.31% | -2.78% | +10.47% | +30.49% | 14.32B | ||
| +1.93% | -3.55% | +74.20% | +39.37% | 13.03B | ||
| Average | +0.49% | -4.23% | +60.98% | +104.14% | 29.32B | |
| Weighted average by Cap. | +0.40% | -4.51% | +73.05% | +123.51% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
















